This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Nearest Resistance: $21
Nearest Support: $14
Catalyst: Q2 Earnings, Downgrade
Small-cap medical device maker
Mako Surgical(MAKO) is getting utterly shellacked today, down more than 40% this afternoon. When a small-cap name makes the list of the most-active stocks in the market, you know something big is going on -- and it's clear from Mako's price action today that that something isn't good. A big downgrade from
Goldman Sachs (GS) after yesterday's opaque (but negative) earnings call was the big precipitating factor for Mako.
>>5 Health Care Stocks Setting Up to Break Out
Mako is in freefall right now, and it'd be a mistake to think that today's selloff is the end of it. Shares gapped down hard this morning, but they've been in a sustained downtrend since April, a time over which the stock's value declined by close to 65%. Mako's fundamentals might attract some bargain hunters at these levels, especially given that it has plenty of liquidity and no debt on its balance sheet.
Mako may be cheap by some measures, but it's far enough away from support that it could get much more cheap in the near-term. I'd recommend sitting this one out.